Decision guides
Step-by-step reading guides help distinguish motivation, expectations, possible risks, and unanswered questions before a person treats a compelling story as a basis for action.
Independent information services
Services
Guides, comparisons, and research summaries for adults, families, and care-seeking professionals evaluating ibogaine treatment versus ayahuasca—without presenting either option as established care.
01 — Orientation
Information built for a consequential decision
Bright Basin 93 organizes difficult questions into practical, plain-language resources. The goal is not to direct anyone toward a substance or program, but to make the decision process more careful, more specific, and easier to discuss.
Start with the core comparison of ibogaine and ayahuasca for a shared frame of reference, then use these information services to examine evidence, safety, legality, screening, setting, and aftercare. Our approach to independence and source review explains the standards behind this work.
02 — Signature framework
Four ways to examine the choice
Each service is informational: a way to identify questions, not a substitute for medical, legal, or mental-health advice.
Side-by-side context
Comparisons separate differences in setting, duration, reported experience, legal context, and the quality of available evidence so that unlike claims are not collapsed into one conclusion.
Research summaries
Plain-language summaries identify what a study can and cannot establish, including the difference between preliminary findings, observation, anecdotes, and established care.
Screening & quality prompts
Practical question sets help readers assess safety claims, screening practices, emergency planning, facilitator roles, and aftercare without assuming that a program’s marketing answers them.
03 — Evidence in context
A comparison is only useful when it keeps distinctions intact
Ibogaine and ayahuasca are often discussed together, yet they carry different histories, settings, claims, legal contexts, and risks. The ibogaine overview identifies it as a naturally occurring psychoactive alkaloid, while descriptions of ayahuasca commonly refer to a prepared psychoactive drink rather than a single compound.
Good information slows the leap from possibility to certainty.
04 — Safety lens
Questions that should not be left vague
- What is known, what is uncertain, and what is being claimed beyond the available evidence?
- What screening, emergency planning, medication review, and follow-up are described—and what is not described?
- What legal restrictions apply where a person lives or where a program operates? The U.S. controlled-substances schedule is one official starting point for checking federal classification.
- How will someone evaluate claims involving neurological recovery? For focused background, review the independent material on ibogaine and brain injury questions alongside broader safety and evidence considerations.
05 — Common questions
A direct answer is sometimes an honest limit
Are ibogaine and ayahuasca established care?
No. Bright Basin 93 presents information for careful evaluation and does not present either option as established care. Anecdotes, marketing language, and preliminary research should not be treated as proof of an outcome.
What makes a comparison trustworthy?
A useful comparison names uncertainty, distinguishes research from personal accounts, and does not skip over screening, interaction concerns, legality, or aftercare. The safety and screening considerations expand the questions that deserve specific answers.
Where should families begin?
Begin with the questions that are easiest to overlook: what is being promised, what would count as a warning sign, who is responsible for emergency decisions, and what support exists afterward. A structured program quality checklist can help keep those questions visible.
A careful next step
Use information to clarify the decision—not to rush it.
Bright Basin 93 is an independent resource for comparing ibogaine and ayahuasca with attention to evidence, safety, screening, legality, and aftercare.